NCT03365791

Who might be able to join this trial:

• You have already received at least one previous treatment for your cancer, but no more than five previous treatments in total.
• You have been diagnosed with a solid tumour or a type of lymphoma (called Diffuse Large B-cell Lymphoma) that has been confirmed by a pathology test, and your cancer can be measured using medical scans.

Who may not be able to join:

• You have had a severe allergic reaction to a type of medication called a monoclonal antibody in the past.
• You have significant heart problems or a condition that affects how well your heart works.
• You currently have, or are suspected to have, an autoimmune disease (where the immune system attacks the body), or you have had one within the last three years — though some exceptions may apply (confirm with trial site).
• You have a second, separate cancer that was diagnosed within the last three years before starting the trial.
• You have previously been treated with certain immunotherapy medicines that target proteins called PD-1, PD-L1, CTLA-4, or LAG-3 — though people who had skin or hormone side effects from PD-1/PD-L1 treatment and were successfully treated for those may not be automatically excluded (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.